A Phase I, Open-Label, Randomized, 2-Way Crossover Trial in 40 Healthy Subjects to Investigate the Potential Pharmacokinetic Interactions Between Telaprevir and Darunavir/Ritonavir and Between Telaprevir and Fosamprenavir/Ritonavir at Steady-State.
Phase of Trial: Phase I
Latest Information Update: 16 Dec 2010
At a glance
- Drugs Darunavir; Fosamprenavir; Ritonavir; Telaprevir
- Indications HIV infections
- Focus Pharmacokinetics
- Sponsors Janssen R&D Ireland
- 16 Dec 2010 Actual initiation date changed from May 2008 to Jun 2008 as reported by ClinicalTrials.gov.
- 06 Nov 2008 New trial record.